Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/204109
Share/Export:
logo share SHARE logo core CORE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Title

Chimeric camel/human heavy-chain antibodies protect against MERS-CoV infection

AuthorsStalin Raj, V.; Okba, Nisreen M. A.; Gutierrez-Alvarez, Francisco J. ; Drabek, Dubravka; Dieren, Brenda van; Widagdo, W.; Lamers, Mart M.; Widjaja, Ivy; Fernandez-Delgado, Raúl ; Solá Gurpegui, Isabel CSIC ORCID ; Bensaid, Albert; Koopmans, Marion P.; Segalés, Joaquim; Osterhaus, Albert D. M. E.; Bosch, Berend Jan; Enjuanes Sánchez, Luis CSIC ORCID ; Haagmans, Bart L.
Issue Date8-Aug-2018
PublisherAmerican Association for the Advancement of Science
CitationScience advances 4(8): eaas9667 (2018)
AbstractMiddle East respiratory syndrome coronavirus (MERS-CoV) continues to cause outbreaks in humans as a result of spillover events from dromedaries. In contrast to humans, MERS-CoV¿exposed dromedaries develop only very mild infections and exceptionally potent virus-neutralizing antibody responses. These strong antibody responses may be caused by affinity maturation as a result of repeated exposure to the virus or by the fact that dromedaries¿ apart from conventional antibodies¿have relatively unique, heavy chain¿only antibodies (HCAbs).
Publisher version (URL)http://dx.doi.org/10.1126/sciadv.aas9667
URIhttp://hdl.handle.net/10261/204109
DOI10.1126/sciadv.aas9667
Identifiersdoi: 10.1126/sciadv.aas9667
e-issn: 2375-2548
pmid: 30101189
Appears in Collections:(CNB) Artículos
(PTI Salud Global) Colección Especial COVID-19




Files in This Item:
File Description SizeFormat
722163.pdf1,22 MBUnknownView/Open
Show full item record
Review this work

PubMed Central
Citations

44
checked on Aug 31, 2023

SCOPUSTM   
Citations

61
checked on Sep 16, 2023

WEB OF SCIENCETM
Citations

50
checked on Sep 13, 2023

Page view(s)

182
checked on Sep 20, 2023

Download(s)

139
checked on Sep 20, 2023

Google ScholarTM

Check

Altmetric

Altmetric


Related articles:


This item is licensed under a Creative Commons License Creative Commons